Impact of BCG vaccination on incidence of tuberculosis disease in southern Ireland

Simple item page
dc.contributor.authorSweeney, Eileen
dc.contributor.authorDahly, Darren L.
dc.contributor.authorSeddiq, Nahed
dc.contributor.authorCorcoran, Gerard
dc.contributor.authorHorgan, Mary
dc.contributor.authorSadlier, Corinna
dc.date.accessioned2019-11-20T05:05:40Z
dc.date.available2019-11-20T05:05:40Z
dc.date.issued2019-05-09
dc.description.abstractTuberculosis (TB) is the ninth leading cause of death worldwide and the leading cause from a single infectious agent. Bacillus Calmette-Guerin (BCG) is the only licensed vaccine for TB, yet its efficacy remains debated with variations in vaccine sub-strains, policies, and practices observed across the world. Three BCG vaccination policies were implemented across adjoining regions in the South West of Ireland from 1972; neonatal vaccination (vaccinated Region-A), vaccination of children aged 10–12 years (vaccinated Region-B) and no vaccination (unvaccinated Region-C). The aim of this study is to examine the impact of different BCG vaccination policies on incidence of TB disease in the South of Ireland over a 13-year period.en
dc.description.statusPeer revieweden
dc.description.versionPublished Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.articleid397en
dc.identifier.citationSweeney, E., Dahly, D., Seddiq, N., Corcoran, G., Horgan, M. and Sadlier, C. (2019) 'Impact of BCG vaccination on incidence of tuberculosis disease in southern Ireland'. BMC infectious diseases, 19(1), 397. (5pp). DOI:10.1186/s12879-019-4026-zen
dc.identifier.doi10.1186/s12879-019-4026-zen
dc.identifier.eissn1471-2334
dc.identifier.endpage5en
dc.identifier.issued1en
dc.identifier.journaltitleBMC Infectious Diseasesen
dc.identifier.startpage1en
dc.identifier.urihttps://hdl.handle.net/10468/9108
dc.identifier.volume19en
dc.language.isoenen
dc.publisherBioMed Centralen
dc.relation.urihttps://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-019-4026-z
dc.rights© The Author(s), 2019. License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.en
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stateden
dc.subjectBacille Camille-Guerin (BCG)en
dc.subjectMycobacterium tuberculosis (MTB)en
dc.subjectVaccinesen
dc.titleImpact of BCG vaccination on incidence of tuberculosis disease in southern Irelanden
dc.typeArticle (peer-reviewed)en
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
s12879-019-4026-z.pdf
Size:
903.96 KB
Format:
Adobe Portable Document Format
Description:
Published version
Download
Thumbnail Image
Name:
12879_2019_4026_MOESM1_ESM.png
Size:
1.09 MB
Format:
Portable Network Graphics
Description:
Supplementary file 1
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Public Health - Journal Articles
Medicine - Journal Articles
Microbiology - Journal Articles